大塚ホールディングスの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2024/03/26 | 6,262 | 6,312 | 6,212 | 6,289 | -29 | -0.5% | 764,300 |
2024/03/25 | 6,480 | 6,480 | 6,310 | 6,318 | -150 | -2.3% | 873,200 |
2024/03/22 | 6,431 | 6,510 | 6,429 | 6,468 | +60 | +0.9% | 1,116,000 |
2024/03/21 | 6,407 | 6,431 | 6,352 | 6,408 | +82 | +1.3% | 1,146,200 |
2024/03/19 | 6,280 | 6,326 | 6,192 | 6,326 | +2 | ±0% | 1,278,500 |
2024/03/18 | 6,150 | 6,360 | 6,149 | 6,324 | +264 | +4.4% | 1,199,800 |
2024/03/15 | 6,030 | 6,113 | 6,010 | 6,060 | +63 | +1.1% | 1,209,200 |
2024/03/14 | 5,994 | 6,052 | 5,960 | 5,997 | -9 | -0.1% | 1,113,600 |
2024/03/13 | 5,995 | 6,008 | 5,938 | 6,006 | +24 | +0.4% | 988,300 |
2024/03/12 | 6,000 | 6,006 | 5,895 | 5,982 | +25 | +0.4% | 996,200 |
2024/03/11 | 6,016 | 6,023 | 5,855 | 5,957 | -121 | -2% | 1,160,200 |
2024/03/08 | 6,000 | 6,078 | 5,927 | 6,078 | +78 | +1.3% | 1,667,900 |
2024/03/07 | 6,019 | 6,074 | 5,972 | 6,000 | -26 | -0.4% | 1,053,600 |
2024/03/06 | 6,089 | 6,120 | 6,019 | 6,026 | -53 | -0.9% | 1,117,800 |
2024/03/05 | 6,004 | 6,088 | 6,001 | 6,079 | +34 | +0.6% | 888,900 |
2024/03/04 | 6,006 | 6,093 | 6,004 | 6,045 | -9 | -0.1% | 980,400 |
2024/03/01 | 6,059 | 6,096 | 6,011 | 6,054 | -28 | -0.5% | 756,800 |
2024/02/29 | 6,147 | 6,169 | 6,055 | 6,082 | -70 | -1.1% | 1,335,900 |
2024/02/28 | 6,088 | 6,173 | 6,063 | 6,152 | +78 | +1.3% | 1,356,600 |
2024/02/27 | 5,840 | 6,087 | 5,840 | 6,074 | +302 | +5.2% | 2,271,000 |
2024/02/26 | 5,683 | 5,814 | 5,683 | 5,772 | +134 | +2.4% | 1,237,200 |
2024/02/22 | 5,584 | 5,678 | 5,580 | 5,638 | +42 | +0.8% | 995,400 |
2024/02/21 | 5,559 | 5,623 | 5,542 | 5,596 | +37 | +0.7% | 993,400 |
2024/02/20 | 5,527 | 5,625 | 5,506 | 5,559 | +47 | +0.9% | 862,000 |
2024/02/19 | 5,574 | 5,624 | 5,495 | 5,512 | -90 | -1.6% | 806,200 |
2024/02/16 | 5,482 | 5,661 | 5,482 | 5,602 | +174 | +3.2% | 1,735,600 |
2024/02/15 | 5,440 | 5,506 | 5,338 | 5,428 | -6 | -0.1% | 2,480,200 |
2024/02/14 | 5,410 | 5,614 | 5,261 | 5,434 | +75 | +1.4% | 3,347,500 |
2024/02/13 | 5,044 | 5,359 | 5,030 | 5,359 | -285 | -5% | 3,274,800 |
2024/02/09 | 5,646 | 5,777 | 5,623 | 5,644 | -14 | -0.2% | 1,397,900 |
2024/02/08 | 5,621 | 5,689 | 5,577 | 5,658 | +28 | +0.5% | 1,045,900 |
2024/02/07 | 5,635 | 5,707 | 5,583 | 5,630 | -46 | -0.8% | 850,100 |
2024/02/06 | 5,694 | 5,745 | 5,642 | 5,676 | -65 | -1.1% | 870,900 |
2024/02/05 | 5,695 | 5,764 | 5,689 | 5,741 | +53 | +0.9% | 578,200 |
2024/02/02 | 5,761 | 5,779 | 5,685 | 5,688 | -49 | -0.9% | 703,200 |
2024/02/01 | 5,801 | 5,815 | 5,733 | 5,737 | -87 | -1.5% | 591,400 |
2024/01/31 | 5,699 | 5,824 | 5,690 | 5,824 | +49 | +0.8% | 916,100 |
2024/01/30 | 5,855 | 5,855 | 5,757 | 5,775 | -65 | -1.1% | 854,300 |
2024/01/29 | 5,805 | 5,868 | 5,805 | 5,840 | +55 | +1% | 730,500 |
2024/01/26 | 5,794 | 5,817 | 5,752 | 5,785 | +28 | +0.5% | 813,300 |
2024/01/25 | 5,773 | 5,825 | 5,747 | 5,757 | -46 | -0.8% | 601,300 |
2024/01/24 | 5,839 | 5,873 | 5,786 | 5,803 | -108 | -1.8% | 738,100 |
2024/01/23 | 5,876 | 5,974 | 5,871 | 5,911 | +50 | +0.9% | 720,500 |
2024/01/22 | 5,836 | 5,874 | 5,816 | 5,861 | +71 | +1.2% | 504,400 |
2024/01/19 | 5,828 | 5,847 | 5,738 | 5,790 | -34 | -0.6% | 933,500 |
2024/01/18 | 5,836 | 5,872 | 5,787 | 5,824 | +16 | +0.3% | 923,300 |
2024/01/17 | 5,816 | 5,892 | 5,787 | 5,808 | +17 | +0.3% | 893,100 |
2024/01/16 | 5,864 | 5,871 | 5,774 | 5,791 | -114 | -1.9% | 770,400 |
2024/01/15 | 5,803 | 5,915 | 5,790 | 5,905 | +71 | +1.2% | 624,400 |
2024/01/12 | 5,960 | 5,977 | 5,819 | 5,834 | -34 | -0.6% | 1,389,900 |
301~
350
件表示中 / 3548件
類似銘柄と比較する
現在ご覧いただいている「大塚HD」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
大塚HD | 719,100円 | +2.2% | +10.2% | 1.67% | 13.81倍 | 1.39倍 |
|
国内製薬大手で抗精神病薬が主力。ポカリスエットなど機能性食品も拡大。世界90カ所に工場 |
武 田 | 434,500円 | -1.1% | +75.3% | 4.60% | 29.76倍 | 0.98倍 |
|
国内製薬首位。がん、中枢神経、消化器、希少疾患等に重点。巨額買収で世界売上上位10強入り |
第一三共 | 345,200円 | +6.0% | +4.0% | 2.26% | 21.43倍 | 3.96倍 |
|
国内製薬大手。循環器と感染症薬強い。英アストラゼネカ社と提携し、がん領域の開拓中 |
アステラス薬 | 138,300円 | +0.9% | +380.2% | 5.64% | 19.05倍 | 1.64倍 |
|
医薬品国内2位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
塩野義 | 249,600円 | +20.9% | +10.6% | 2.64% | 11.80倍 | 1.56倍 |
|
抗HIV薬が大型製品に。感染症、疼痛・中枢神経領域に強み。米国に積極展開。欧州、アジア開拓 |
市場注目の銘柄
チャート関連のコラム